These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 1434212)

  • 1. [The mechanism and specificity of IL-1 inhibitory factor released from human alveolar macrophages].
    Takeuchi M; Aung H; Nagai S
    Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Aug; 30(8):1409-16. PubMed ID: 1434212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of IL-1 inhibitory factor released from human alveolar macrophages as IL-1 receptor antagonist.
    Takeuchi M; Nagai S; Nakada H; Aung H; Satake N; Kaneshima H; Izumi T
    Clin Exp Immunol; 1992 Apr; 88(1):181-7. PubMed ID: 1532925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mitogenic factor, released by stimulated human mononuclear cells and distinct from interleukin 2 (IL 2), B cell growth factor (BCGF), and interleukin 1 (IL 1).
    Kasakura S; Taguchi M; Watanabe Y; Okubo T; Murachi T; Uchino H; Hanaoka M
    J Immunol; 1984 Dec; 133(6):3084-90. PubMed ID: 6238094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Quantitative evaluation of gene expression of IL-1 beta and IL-1 receptor antagonist (IL-1ra) from alveolar macrophages in idiopathic pulmonary fibrosis (IPF) and sarcoidosis].
    Shimoji T; Nagai S; Takeuchi M; Saito A; Izumi T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Nov; 31(11):1409-15. PubMed ID: 8277611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An IL-1 inhibitor from human monocytes. Production and characterization of biologic properties.
    Arend WP; Joslin FG; Thompson RC; Hannum CH
    J Immunol; 1989 Sep; 143(6):1851-8. PubMed ID: 2528582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth-promoting activity of IL-1 alpha, IL-6, and tumor necrosis factor-alpha in combination with IL-2, IL-4, or IL-7 on murine thymocytes. Differential effects on CD4/CD8 subsets and on CD3+/CD3- double-negative thymocytes.
    Suda T; Murray R; Guidos C; Zlotnik A
    J Immunol; 1990 Apr; 144(8):3039-45. PubMed ID: 1969882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cultured alveolar macrophages from patients with idiopathic pulmonary fibrosis (IPF) show dysregulation of lipopolysaccharide-induced tumor necrosis factor-alpha (TNF-alpha) and interleukin-10 (IL-10) inductions.
    Freeburn RW; Armstrong L; Millar AB
    Eur Cytokine Netw; 2005; 16(1):5-16. PubMed ID: 15809201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of IL-6 inhibitory activity in cultured cell supernatants and lysates.
    Twigg HL; Wilkes DS; Soliman DM
    J Lab Clin Med; 1994 Aug; 124(2):283-92. PubMed ID: 8051493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune functions of tumor necrosis factor. I. Tumor necrosis factor induces apoptosis of mouse thymocytes and can also stimulate or inhibit IL-6-induced proliferation depending on the concentration of mitogenic costimulation.
    Hernández-Caselles T; Stutman O
    J Immunol; 1993 Oct; 151(8):3999-4012. PubMed ID: 8409382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Changes in interleukin-1 released by pulmonary alveolar macrophage in patients with interstitial lung disease].
    Li ZH
    Zhonghua Jie He He Hu Xi Za Zhi; 1993 Feb; 16(2):90-2, 124. PubMed ID: 8221960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of inflammatory cytokine secretion by human alveolar macrophages.
    Losa García JE; Rodríguez FM; Martín de Cabo MR; García Salgado MJ; Losada JP; Villarón LG; López AJ; Arellano JL
    Mediators Inflamm; 1999; 8(1):43-51. PubMed ID: 10704089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a specific 20- to 25-kD interleukin-1 inhibitor from cultured human lung macrophages.
    Galve-de Rochemonteix B; Nicod LP; Junod AF; Dayer JM
    Am J Respir Cell Mol Biol; 1990 Oct; 3(4):355-61. PubMed ID: 2144978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of osteoclast-activating factor activity of multiple myeloma bone marrow cells by different interleukin-1 inhibitors.
    Torcia M; Lucibello M; Vannier E; Fabiani S; Miliani A; Guidi G; Spada O; Dower SK; Sims JE; Shaw AR; Dinarello CA; Garaci E; Cozzolino F
    Exp Hematol; 1996 Jul; 24(8):868-74. PubMed ID: 8690044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tenidap modulates cytoplasmic pH and inhibits anion transport in vitro. II. Inhibition of IL-1 beta production from ATP-treated monocytes and macrophages.
    Laliberte R; Perregaux D; Svensson L; Pazoles CJ; Gabel CA
    J Immunol; 1994 Sep; 153(5):2168-79. PubMed ID: 8051418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin 2 receptors are expressed by alveolar macrophages during pulmonary sarcoidosis and are inducible by lymphokine treatment of normal human lung macrophages, blood monocytes, and monocyte cell lines.
    Hancock WW; Muller WA; Cotran RS
    J Immunol; 1987 Jan; 138(1):185-91. PubMed ID: 3097144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TNF alpha mRNA, but not IL-1 beta, is differentially expressed in lung macrophages of patients with active pulmonary sarcoidosis.
    Kaneshima H; Nagai S; Shimoji T; Tsutsumi T; Mikuniya T; Satake N; Izumi T
    Sarcoidosis; 1994 Mar; 11(1):19-25. PubMed ID: 8036337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin 1 inhibitory activity secreted by a human myelomonocytic cell line (M20).
    Barak V; Treves AJ; Yanai P; Halperin M; Wasserman D; Biran S; Braun S
    Eur J Immunol; 1986 Nov; 16(11):1449-52. PubMed ID: 3490987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autocrine growth of T cells independent of interleukin 2: identification of interleukin 4 (IL 4, BSF-1) as an autocrine growth factor for a cloned antigen-specific helper T cell.
    Kupper T; Horowitz M; Lee F; Robb R; Flood PM
    J Immunol; 1987 Jun; 138(12):4280-7. PubMed ID: 2953803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphokine-mediated induction of antigen-presenting ability in thymic stromal cells.
    Ransom J; Fischer M; Mercer L; Zlotnik A
    J Immunol; 1987 Oct; 139(8):2620-8. PubMed ID: 3116089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thymic stroma-derived T-cell inhibitory factor (TSTIF) 1. TSTIF induces inhibition of antigen-stimulated T-cell proliferation.
    Kita Y; Tai XG; Hikita I; Sogoh S; Nishitani Y; Watanabe S; Sakata T; Iwagami S; Teraoka H; Ogata M
    Thymus; 1993 May; 21(3):159-75. PubMed ID: 8236375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.